×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KOD – kodiak sciences inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KOD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/27
04:12 pm
kod
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Low
Report
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
3/27
04:01 pm
kod
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
Medium
Report
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
3/10
05:24 pm
kod
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy [Yahoo! Finance]
Medium
Report
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy [Yahoo! Finance]
3/10
04:39 pm
kod
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy
Low
Report
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy
2/4
07:30 am
kod
Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025
Low
Report
Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025
1/7
06:00 am
kod
Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
1/6
02:21 pm
kod
KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates [Yahoo! Finance]
Low
Report
KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/27
04:20 pm
kod
Form 10-K Kodiak Sciences Inc. For: Dec 31
Medium
Report
Form 10-K Kodiak Sciences Inc. For: Dec 31
3/27
04:10 pm
kod
Form 8-K Kodiak Sciences Inc. For: Mar 27
Medium
Report
Form 8-K Kodiak Sciences Inc. For: Mar 27
2/14
04:03 pm
kod
Form SCHEDULE 13G/A Kodiak Sciences Inc. Filed by: PERLROTH VICTOR
Low
Report
Form SCHEDULE 13G/A Kodiak Sciences Inc. Filed by: PERLROTH VICTOR
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/2
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
72.5%
12/4 Kodiak Sciences prices $276M equity offering [Seeking Alpha] 49.8%
9/15 Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting 17.2%
11/15 Form EFFECT Kodiak Sciences Inc. 16.6%
12/24 Kodiak Sciences Inc. (NYSE: KOD) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $82.00 price target on the stock. 15.3%
10/10 Form 8-K Kodiak Sciences Inc. For: Oct 04 13.3%
3/18 Form 4 Kodiak Sciences Inc. For: Mar 16 Filed by: BAKER FELIX 12.5%
5/15 Form S-8 Kodiak Sciences Inc. 12.2%
4/29 Form DEFA14A Kodiak Sciences Inc. 9.1%
9/4 Kodiak Sciences Announces Upcoming Presentations at EURETINA Meeting 8.3%
12/4 Kodiak Sciences prices $276M equity offering [Seeking Alpha] 49.8%
9/15 Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at The Retina Society Annual Meeting 17.2%
11/15 Form EFFECT Kodiak Sciences Inc. 16.6%
12/24 Kodiak Sciences Inc. (NYSE: KOD) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $82.00 price target on the stock. 15.3%
10/10 Form 8-K Kodiak Sciences Inc. For: Oct 04 13.3%
3/18 Form 4 Kodiak Sciences Inc. For: Mar 16 Filed by: BAKER FELIX 12.5%
5/15 Form S-8 Kodiak Sciences Inc. 12.2%
4/29 Form DEFA14A Kodiak Sciences Inc. 9.1%
9/4 Kodiak Sciences Announces Upcoming Presentations at EURETINA Meeting 8.3%
TOP News Decliners
3/16
Q4/2019 12/31/2019 EPS -0.400 ZacksConsensus N/A ActVsEst N/A - N/A
-24.2%
12/4 Form 4 Kodiak Sciences Inc. For: Dec 02 Filed by: Liang Hong -11.0%
11/20 Form 8-K Kodiak Sciences Inc. For: Nov 18 -10.5%
8/14 Q2/2019 6/30/2019 EPS -0.310 ZacksConsensus N/A ActVsEst N/A - N/A -9.9%
2/26 Form SC 13D/A Kodiak Sciences Inc. Filed by: BAKER BROS. ADVISORS LP -8.4%
4/6 Form 4 Kodiak Sciences Inc. For: Apr 02 Filed by: Liang Hong -8.2%
12/2 Kodiak Sciences Inc. (NYSE: KOD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock. -7.9%
4/22 Form 4 Kodiak Sciences Inc. For: Apr 20 Filed by: EHRLICH JASON -6.9%
11/12 Q3/2019 9/30/2019 EPS -0.330 ZacksConsensus -0.330 ActVsEst 0.000 - In-Line -6.1%
11/18 3 Biotech Stock Rockets With More Fuel in the Tank [The Motley Fool] -5.6%
12/4 Form 4 Kodiak Sciences Inc. For: Dec 02 Filed by: Liang Hong -11.0%
11/20 Form 8-K Kodiak Sciences Inc. For: Nov 18 -10.5%
8/14 Q2/2019 6/30/2019 EPS -0.310 ZacksConsensus N/A ActVsEst N/A - N/A -9.9%
2/26 Form SC 13D/A Kodiak Sciences Inc. Filed by: BAKER BROS. ADVISORS LP -8.4%
4/6 Form 4 Kodiak Sciences Inc. For: Apr 02 Filed by: Liang Hong -8.2%
12/2 Kodiak Sciences Inc. (NYSE: KOD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock. -7.9%
4/22 Form 4 Kodiak Sciences Inc. For: Apr 20 Filed by: EHRLICH JASON -6.9%
11/12 Q3/2019 9/30/2019 EPS -0.330 ZacksConsensus -0.330 ActVsEst 0.000 - In-Line -6.1%
11/18 3 Biotech Stock Rockets With More Fuel in the Tank [The Motley Fool] -5.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: